Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Risks in aspirin as CV prevention

This article was originally published in The Tan Sheet

Executive Summary

Patients and physicians should consider factors including age, gender, diabetes, blood pressure, cholesterol levels, smoking and risk of gastrointestinal bleeding before deciding to use aspirin to prevent heart attacks or strokes, an Agency for Healthcare Research and Quality panel recommends. In a March 17 Annals of Internal Medicine study, the U.S. Preventive Services Task Force found the more risk factors people have, the more likely they are to benefit from aspirin. The panel reviewed evidence from the National Institutes of Health's Women's Health Study published since its previous review of the topic in 2002. The task force recommends when the benefits outweigh the potential for GI bleeding, men between the ages of 45 and 79 should use aspirin to reduce their risk for heart attacks and women between the ages of 55 and 79 should use aspirin to reduce their risk for ischemic stroke

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102741

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel